Fagron NV (EBR: FAGR)
Belgium flag Belgium · Delayed Price · Currency is EUR
19.16
-0.02 (-0.10%)
Sep 3, 2024, 5:26 PM CET

Fagron NV Company Description

Fagron NV, a pharmaceutical compounding company, delivers personalized pharmaceutical care to hospitals, pharmacies, clinics, and patients worldwide.

It operates in three segments: Essentials, Brands, and Compounding Services. The company also innovates concepts, vehicles, and formulations for pharmaceutical compounding.

Its products include DiluCap, a line of excipients to compound every capsule formulation; Imuno TF Complex helps in regulation of immune responses; Pigmerise, a natural phytocomplex for hypopigmentation disorders; Pentravan uses for avoiding first-pass metabolism and preventing gastrointestinal erosion; Nourisil MD, a first line therapy for prevention and treatment of scars ang keloids; Neogen, a line of hair care products; TrichoConcept used to treat alopecia; Fagron Advanced Derma for basic skincare, compound pharmaceutical treatment, and individualized dermatological care; and SyrSpend SF that provides pharmaceutical stability, dosage consistency, and patient comfort.

In addition, the company offers education and training program to prescribers and pharmacists through the Fagron Academy.

The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium.

Fagron NV
Fagron NV logo
Country Belgium
Founded 1990
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 3,647
CEO Rafael Padilla

Contact Details

Address:
Venecoweg 20A
Nazareth, 9810
Belgium
Phone 32 8 001 28 80
Website fagron.com

Stock Details

Ticker Symbol FAGR
Exchange Euronext Brussels
Fiscal Year January - December
Reporting Currency EUR
ISIN Number BE0003874915
SIC Code 5047